Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Medical cannabis formulation kills breast cancer cells in trial

June 28, 2021 Sales and Marketing breast cancer, medical cannabis, oncology

UK-based pharma company, Apollon Formularies, have announced that their medical cannabis formulations were successful in killing triple-negative breast cancer (TNBC) …
News
astrazeneca_plaque_web

AstraZeneca ordered to deliver 50 million vaccine doses to EU

June 21, 2021 Sales and Marketing

A Belgian court has instructed AstraZeneca to deliver 50 million COVID-19 shots to the European Union following a dispute on …
News

EU approves Onureg for patients with acute myeloid leukemia

June 21, 2021 Sales and Marketing

The European Commission has approved Onureg as frontline oral maintenance therapy for patients with a broad range of acute myeloid …
News

Alzheimer’s drug approval: Advocacy group calls for FDA resignations

June 21, 2021 Sales and Marketing

Public Citizen, the US consumer advocacy group, has called for the resignation of three top FDA officials following the approval …
News
novartis_window

Novartis’s Zolgensma for SMA shows ‘extraordinary’ results

June 21, 2021 Sales and Marketing

New late-breaker data from the Phase III trial for Zolgensma, the world’s most expensive drug, has shown positive results. Zolgensma …
News
sanofi_hq__boetie_hall_web

EU approves Aubagio for children living with MS

June 21, 2021 Sales and Marketing

The EU has approved Aubagio (teriflunomide) for the treatment of paediatric patients 10 to 17 years of age with relapsing-remitting …
News
janssen_latest_logo_on_sign_closer

Janssen CLL treatment combination sees success in trials

June 14, 2021 Sales and Marketing CLL, Janssen

Janssen has announced positive data from its Phase III GLOW study, with the combination of imbruvica (ibrutinib) plus venetoclax (I+V) …
News
astrazeneca_sign_sky

EMA official recommends avoiding AstraZeneca vaccine

June 14, 2021 Sales and Marketing

A senior executive at the EMA recommended abandoning the use of the AstraZeneca vaccine in the EU where alternatives are …
News

NICE recommends treatments for rare form of colorectal cancer

June 14, 2021 Sales and Marketing

NICE has recommended BMS’s nivolumab plus ipilimumab (also known as Opdivo and Yervoy) to treat people with a rare form …
News
image_readtop_2018_569751_15365546683454581

Experimental COVID antibody treatment successful in trials

June 14, 2021 Sales and Marketing COVID-19, antibody therapy, celltrion, phase III

Celltrion has announced positive top-line data for its experimental antibody COVID-19 treatment, with Phase III trials finding it safe and …
News
johnson_and_johnson_jj

Germany demands that J&J replace contaminated vaccine doses

June 14, 2021 Sales and Marketing

Germany’s health ministry has demanded that J&J must deliver 6.5 million COVID-19 vaccine doses to Germany in July to make …
News

Astronomy & cancer: Researchers join forces to study CUP

June 7, 2021 Sales and Marketing oncology

Astronomers from Durham University have joined forces with cancer researchers to advance the diagnosis and treatment of cancer of unknown …
News

UK vaccination update

June 7, 2021 Sales and Marketing

With 21 June fast approaching, and the Delta variant rising in the UK, here’s the latest vaccine update. Firstly, the …
News

AstraZeneca vs GSK: Cancer drug court battle could cost hundreds of millions

June 7, 2021 Sales and Marketing AstraZeneca, GSK, court

AstraZeneca has launched a court case against Glaxo Smith Kline (GSK), in a claim that could reach hundreds of millions …
News
covid_cell_1_20

MHRA confirms registration of Avacta’s lateral flow test

June 7, 2021 Sales and Marketing COVID-19, EU, MHRA, lateral flow test

Avacta has announced that the MHRA has confirmed registration of the AffiDX SARS-CoV-2 antigen lateral flow test, which allows the …
News
The Gateway to Local Adoption Series

Latest content

AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials

October 4, 2026

Brenntag and dsm-firmenich expand biopharma vitamin partnership

October 4, 2026

CeramTec expands German production capacity for orthopaedic ceramics

October 2, 2026

Migraine annual economic and quality-of-life burden in UK

October 1, 2026

bit.bio expands human heart cell portfolio through myriamed partnership

September 30, 2026